Plasma Endocan as a Predictor of Cardiovascular Event in Patients with End-Stage Renal Disease on Hemodialysis

Endocan, a potential biomarker of endothelial dysfunction, is associated with increased cardiovascular risk. We investigated the utility of plasma endocan for predicting cardiovascular risk in end-stage renal disease (ESRD) patients undergoing hemodialysis. Of the 452 patients in the K-cohort, 354 w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin Sug, Ko, Gang Jee, Kim, Yang Gyun, Lee, So Young, Lee, Dong Young, Jeong, Kyung Hwan, Lee, Sang Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766985/
https://www.ncbi.nlm.nih.gov/pubmed/33352837
http://dx.doi.org/10.3390/jcm9124086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766985/
https://www.ncbi.nlm.nih.gov/pubmed/33352837
http://dx.doi.org/10.3390/jcm9124086

Ejemplares similares